Immortalized human endothelial cells (EAhy926, ATCC) and HEK293 cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS, Hyclone). Human primary microvascular endothelial cells (HMVEC) were purchased from Lonza and maintained in EGM-2 media with supplements supplied by the vendor; three different batches of primary cells were used in this study as previously described18 . Primary murine cardiac microvascular endothelial cells were isolated as previously described19 . Angiotensin II was purchased from Sigma. SNAI2/SLUG promoter-luciferase constructs20 (link), COL1A2 promoter-luciferase constructs21 (link), BRG1 expression constructs22 , SLUG expression constructs23 (link), Sp1 expression constructs24 (link), and SRF expression constructs25 (link) have been previously described. PFI-3 was purchased from Selleck. Transient transfections were performed with Lipofectamine 2000. Luciferase activities were assayed 24–48 h after transfection using a luciferase reporter assay system (Promega) as previously described26 (link).
Free full text: Click here